These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Surgery and adjuvant chemotherapy of osteosarcoma]. Yamawaki S Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1576-83. PubMed ID: 3460527 [TBL] [Abstract][Full Text] [Related]
3. [Progress and stagnation in chemotherapy protocols for primary osteosarcoma]. Delépine N; Alkallaf S; Cornille H; Markowska B; Delépine G Ann Med Interne (Paris); 2003 Feb; 154(1):12-24. PubMed ID: 12746655 [TBL] [Abstract][Full Text] [Related]
4. Intraarterial Cisplatin and intravenous adriamycin in nonmetastatic osteosarcoma of the extremities: a single institution experience in Taiwan. Chiu TJ; Wang JW; Chen YJ; Tang Y; Huang CH Chang Gung Med J; 2009; 32(1):72-80. PubMed ID: 19292942 [TBL] [Abstract][Full Text] [Related]
5. Selected applications of methotrexate alone and in combination in osteosarcoma. Pratt CB Cancer Treat Rep; 1981; 65 Suppl 1():107-11. PubMed ID: 6976828 [TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor). Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439 [TBL] [Abstract][Full Text] [Related]
7. A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity. Bacci G; Ferrari S; Tienghi A; Bertoni F; Mercuri M; Longhi A; Fiorentini G; Forni C; Bacchini P; Rimondini S; De Giorgi U; Picci P Eur J Surg Oncol; 2001 Feb; 27(1):98-104. PubMed ID: 11237499 [TBL] [Abstract][Full Text] [Related]
8. [Significance of surgical adjuvant chemotherapy in osteosarcoma]. Yamawaki S; Isu K; Ubayama Y; Goto M; Kobayash M; Ishii S; Usui M; Yagi T; Sasaki T Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1430-7. PubMed ID: 3496046 [TBL] [Abstract][Full Text] [Related]
10. High-dose methotrexate used alone and in combination for measurable primary or metastatic osteosarcoma. Pratt CB; Howarth C; Ransom JL; Bowles D; Green AA; Kumar AP; Rivera G; Evans WE Cancer Treat Rep; 1980 Jan; 64(1):11-20. PubMed ID: 6966535 [TBL] [Abstract][Full Text] [Related]
11. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery? Jaffe N; Carrasco H; Raymond K; Ayala A; Eftekhari F Cancer; 2002 Nov; 95(10):2202-10. PubMed ID: 12412175 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy for osteosarcoma at the Singapore General Hospital. Khor TH; Chua EJ; Tan BC; Chia KB Singapore Med J; 1983 Apr; 24(2):95-8. PubMed ID: 6577611 [No Abstract] [Full Text] [Related]
13. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. Goorin AM; Schwartzentruber DJ; Devidas M; Gebhardt MC; Ayala AG; Harris MB; Helman LJ; Grier HE; Link MP; J Clin Oncol; 2003 Apr; 21(8):1574-80. PubMed ID: 12697883 [TBL] [Abstract][Full Text] [Related]
14. Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma. Tsuchiya H; Tomita K; Mori Y; Asada N; Morinaga T; Kitano S; Yamamoto N Anticancer Res; 1998; 18(1B):657-66. PubMed ID: 9584049 [TBL] [Abstract][Full Text] [Related]
15. Adjuvant therapy for osteosarcoma: preoperative and postoperative treatment. Eilber FR; Grant T; Morton DL Cancer Treat Rep; 1978 Feb; 62(2):213-6. PubMed ID: 346209 [TBL] [Abstract][Full Text] [Related]
16. SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients. Le Deley MC; Guinebretière JM; Gentet JC; Pacquement H; Pichon F; Marec-Bérard P; Entz-Werlé N; Schmitt C; Brugières L; Vanel D; Dupoüy N; Tabone MD; Kalifa C; Eur J Cancer; 2007 Mar; 43(4):752-61. PubMed ID: 17267204 [TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy for osteosarcoma. Pratt CB; Rivera G; Shanks E; Kumar AP; Green AA; George S Cancer Treat Rep; 1978 Feb; 62(2):251-7. PubMed ID: 346214 [TBL] [Abstract][Full Text] [Related]
18. Progression of osteosarcoma after high-dose methotrexate: over-rescue by folinic acid. Cohen IJ Pediatr Hematol Oncol; 2003 Dec; 20(8):579-81. PubMed ID: 14578026 [TBL] [Abstract][Full Text] [Related]
19. [Long-term follow-up results after heavy dose chemotherapy of primary malignant bone tumors of the limbs]. Cui TH Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):307-10. PubMed ID: 8174471 [TBL] [Abstract][Full Text] [Related]
20. [The importance of dose intensity in preoperative chemotherapy for osteosarcoma--retrospective analysis of a short intensive chemotherapy regimen preoperatively using high-dose methotrexate and cisplatinum]. Takahashi M; Katagiri H; Sato K; Sugiura H; Yamamura S; Fukaya N; Nakanishi K Gan To Kagaku Ryoho; 1994 Mar; 21(4):459-64. PubMed ID: 8129386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]